Dupliumab therapy for alopecia areata: a case series and review of the literature
AbstractBackground A growing body of research supports the important role of the TH2 axis in alopecia areata (AA). Dupilumab is a humanized monoclonal antibody against IL-4Rα that downregulates TH2 response. Although efficacy has been shown in clinical trials, real-world data on the use of dupilumab...
Saved in:
Main Authors: | Jundong Huang (Author), Jia Jian (Author), Tingting Li (Author), Min Li (Author), Kaifu Luo (Author), Sihan Deng (Author), Yan Tang (Author), Fangfen Liu (Author), Zhixiang Zhao (Author), Wei Shi (Author), Ji Li (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug Survival and Long-term Outcome of Tofacitinib in Patients with Alopecia Areata: A Retrospective Study
by: Jundong Huang, et al.
Published: (2023) -
Complete Blood Collection-based Systemic Inflammation Biomarkers as a Severity Biomarker in Alopecia Areata: A Cross-sectional Study
by: Sihan Deng, et al.
Published: (2024) -
Effectiveness of Tofacitinib in Pre-adolescent Alopecia Areata: A Retrospective Case Series and Literature Review
by: Jundong Huang, et al.
Published: (2023) -
Effectiveness and Predictive Factors of Response to Tofacitinib Therapy in 125 Patients with Alopecia Areata: A Single-centre Real-world Retrospective Study
by: Jundong Huang, et al.
Published: (2023) -
Pattern hair loss distribution: a novel presentation for alopecia areata
by: Jundong Huang, et al.
Published: (2023)